Workflow
科技+传统
icon
Search documents
酱渊引爆酱酒资本圈!年度论坛落地贵阳,目标锚定港股上市
Sou Hu Cai Jing· 2026-01-12 01:51
Core Viewpoint - The forum "Hand in Hand with Jiangyuan: A Global Appreciation" marks Jiangyuan Liquor's strategic plan for 2026-2032, focusing on its goal to list on the Hong Kong Stock Exchange and establish itself as an innovative benchmark in the liquor industry [3][5]. Group 1: Forum Overview - The forum was held at the Guiyang Guanshanhu International Ecological Conference Center, a prestigious venue capable of hosting 3,500 attendees and providing high-end dining services [1]. - Attendees included former leaders from the State-owned Assets Supervision and Administration Commission (SASAC), the China Securities Regulatory Commission (CSRC), and various industry elites, showcasing the event's significance [3][5]. Group 2: Strategic Goals - Jiangyuan Liquor officially announced its seven-year strategic blueprint, aiming for a listing on the Hong Kong Stock Exchange by 2032, with a focus on becoming a leading innovative liquor company [5][6]. - The company emphasizes three core signals: brand certainty, growth potential through innovation, and collaborative partnerships with distributors and industry partners [6]. Group 3: Capital Empowerment - The establishment of the "Gongze Fund" was highlighted as a key initiative to address industry challenges, serving as a connector for capital and a resource integrator for the liquor sector [8]. - The fund aims to facilitate the deep integration of capital with the liquor industry, enhancing its high-quality development [8]. Group 4: Market Positioning - Jiangyuan has achieved a 50% revenue growth in the face of industry challenges, positioning itself as a "new species" in the capital market through its innovative transformation combining technology and tradition [10]. - The company plans to achieve a 100% revenue growth target for 2025, laying a solid foundation for its listing application in 2026 [14]. Group 5: Product and Partnership Strategies - The launch of the strategic product "Jiangyuan Founder Second Generation: Chuan Yu 30" was announced, along with significant incentives for distributors and partners to foster a win-win ecosystem [16]. - The company has successfully enhanced its brand visibility by featuring on the Nasdaq Times Square screen, marking a significant global presence [14].
科技赋能传统 创新引领未来——白云山维一铁皮石斛益生菌荣获FFI2025"年度创新探索奖
Core Insights - The health food industry is experiencing significant growth driven by innovation, with the FFI2025 Food Formula Innovation Forum highlighting future trends in functional foods [1] - Guangzhou Baiyunshan Weiyi Industrial Co., Ltd. showcased its star product, the Dendrobium officinale probiotic solid beverage, which won the "2025 Innovation Exploration Award" through expert evaluation and consumer voting [1][3] Group 1 - The Dendrobium officinale probiotic solid beverage combines traditional medicine and modern probiotic technology, meeting diverse health needs of modern consumers [3] - The expert panel praised the product for its innovative formula that integrates traditional wisdom with modern scientific logic, setting a benchmark in the probiotic market [3] Group 2 - Dendrobium officinale has a long history of medicinal use, documented in ancient texts like "Compendium of Materia Medica," and modern pharmacological studies confirm its health benefits due to over 30 active substances [5] - The company selected the AB21 composite probiotics, which include Lactobacillus plantarum and Lactococcus lactis, achieving a perfect blend of traditional medicine and modern probiotic technology [5] Group 3 - The forum reinforced the "scientific formula" concept of the Dendrobium officinale probiotics, reflecting the company's commitment to quality and consumer health, while promoting a healthy lifestyle [7] - As a key member of the Guangzhou Pharmaceutical Group's health industry, the company leverages its billion-level industrial ecosystem to meet consumer demands with a range of popular health products [7] - The company aims to continue its focus on "technology and traditional Chinese medicine," investing in the modernization and scientific research of traditional health culture to provide innovative and practical health solutions [7]